Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats? Links: <ul><li><a href='https://globalnews.ca/news/9793403/ozempic-canada-scientist-venomous-lizard-weight-loss'>How a Canadian scientist and a venomous lizard helped pave the way for Ozempic</a> </li><li><a href='https://www.frontiersin.org/articles/10.3389/fendo.2019.00155/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Endocrinology&id=440904'>The Discovery and Development of Liraglutide and Semaglutide</a> </li><li><a href='https://www.npr.org/sections/health-shots/2023/08/07/1192279278/ozempic-and-wegovy-maker-courts-prominent-black-leaders-to-get-medicares-favor'>Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor</a> </li><li><a href='https://www.washingtonpost.com/business/2023/06/11/weight-loss-ozempic-wegovy-insurance/'>Insurers clamping down on doctors who prescribe Ozempic for weight loss</a></li><li><a href='https://www.cnn.com/2023/03/17/health/ozempic-shortage-tiktok-telehealth/index.html'>Ozempic prescriptions can be easy to get online. Its popularity for weight loss is hurting those who need it most</a>    </li><li><a href='https://pubmed.ncbi.nlm.nih.gov/31081693/'>Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: real-world evidence from a Mediterranean area</a></li><li><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2306963'>Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity</a></li><li><a href='https://pubmed.ncbi.nlm.nih.gov/35101924/'>Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK</a></li><li><a href='https://www.frontiersin.org/articles/10.3389/fendo.2021.645563/full'>Safety of Semaglutide</a></li><li><a href='https://dom-pubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.14863'>Semaglutide for the treatment of overweight and obesity: A review</a></li><li><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2208601'>Once-Weekly Semaglutide in Adolescents with Obesity</a></li><li><a href='https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.22794'>Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5</a></li><li><a href='https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790392?utm_source=convertkit&utm_medium=email&utm_campaign=The+Truth+About+Diet+Drugs%2C+Part+2%20-%2010222889'>Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases</a></li><li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708309/'>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</a></li><li><a href='https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23859'>Medications and conditions associated with weight loss in patients prescribed semaglutide based on real-world data</a></li></ul>Thanks to <a href='https://freesound.org/people/Doctor_Dreamchip/'>Doctor Dreamchip</a> for our lovely theme song!<a rel="payment" href="https://www.patreon.com/maintenancephase">Support the show</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Ozempic

Maintenance Phase